ImmuCell Corporation (NASDAQ:ICCC – Get Free Report) shares passed above its 200-day moving average during trading on Tuesday . ImmuCell shares last traded at $11.24, with a volume of 8,689 shares changing hands. The business has a fifty day simple moving average of $10.30 and a 200 day simple moving average of $8.16. Militia Capital Management LLC purchased a new position in shares of ImmuCell in the first quarter valued at $114,000. ImmuCell Company Profile(Get Free Report)ImmuCell Corporation (NASDAQ: ICCC) is a biotechnology company that develops, manufactures, and markets immunological products and diagnostic assays designed to enhance animal health in dairy and beef cattle.